United States · FDA National Drug Code directory

Desvenlafaxine Succinate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1331_20d898df-2d0e-462b-a10e-99b51f5c1522
Product NDC
71335-1331
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Desvenlafaxine Succinate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20170301
Source listing expiry
20271231

Source-listed ingredients

  • DESVENLAFAXINE SUCCINATE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1331-1) · 71335-1331-1
  • 28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1331-2) · 71335-1331-2
  • 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1331-3) · 71335-1331-3
  • 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1331-4) · 71335-1331-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →